202 related articles for article (PubMed ID: 9705910)
41. Studies of the binding properties of influenza hemagglutinin receptor-site mutants.
Martín J; Wharton SA; Lin YP; Takemoto DK; Skehel JJ; Wiley DC; Steinhauer DA
Virology; 1998 Feb; 241(1):101-11. PubMed ID: 9454721
[TBL] [Abstract][Full Text] [Related]
42. Additional glycosylation at the receptor binding site of the hemagglutinin (HA) for H5 and H7 viruses may be an adaptation to poultry hosts, but does it influence pathogenicity?
Banks J; Plowright L
Avian Dis; 2003; 47(3 Suppl):942-50. PubMed ID: 14575092
[TBL] [Abstract][Full Text] [Related]
43. Unique Structural Features of Influenza Virus H15 Hemagglutinin.
Tzarum N; McBride R; Nycholat CM; Peng W; Paulson JC; Wilson IA
J Virol; 2017 Jun; 91(12):. PubMed ID: 28404848
[TBL] [Abstract][Full Text] [Related]
44. Molecular mechanisms of serum resistance of human influenza H3N2 virus and their involvement in virus adaptation in a new host.
Matrosovich M; Gao P; Kawaoka Y
J Virol; 1998 Aug; 72(8):6373-80. PubMed ID: 9658077
[TBL] [Abstract][Full Text] [Related]
45. Sulfated glycans containing NeuAcα2-3Gal facilitate the propagation of human H1N1 influenza A viruses in eggs.
Ichimiya T; Okamatsu M; Kinoshita T; Kobayashi D; Ichii O; Yamamoto N; Sakoda Y; Kida H; Kawashima H; Yamamoto K; Takase-Yoden S; Nishihara S
Virology; 2021 Oct; 562():29-39. PubMed ID: 34246113
[TBL] [Abstract][Full Text] [Related]
46. Structure and receptor complexes of the hemagglutinin from a highly pathogenic H7N7 influenza virus.
Yang H; Carney PJ; Donis RO; Stevens J
J Virol; 2012 Aug; 86(16):8645-52. PubMed ID: 22674977
[TBL] [Abstract][Full Text] [Related]
47. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
[TBL] [Abstract][Full Text] [Related]
48. [Variants of influenza H1N1 virus, adapted to mouse lungs and inhibitors of mouse serum inhibitors differ by hemagglutinin characteristics and structure].
Shilov AA; Sinitsyn BV
Vopr Virusol; 2000; 45(3):16-9. PubMed ID: 10867989
[TBL] [Abstract][Full Text] [Related]
49. Neu5Acα2,6Gal and Neu5Acα2,3Gal receptor specificities on influenza viruses determined by a waveguide-mode sensor.
Gopinath SC; Awazu K; Fujimaki M; Shimizu K
Acta Biomater; 2013 Feb; 9(2):5080-7. PubMed ID: 23022889
[TBL] [Abstract][Full Text] [Related]
50. N-glycan profiles in H9N2 avian influenza viruses from chicken eggs and human embryonic lung fibroblast cells.
Chen W; Zhong Y; Su R; Qi H; Deng W; Sun Y; Ma T; Wang X; Yu H; Wang X; Li Z
J Virol Methods; 2017 Nov; 249():10-20. PubMed ID: 28797655
[TBL] [Abstract][Full Text] [Related]
51. Alterations in hemagglutinin receptor-binding specificity accompany the emergence of highly pathogenic avian influenza viruses.
Heider A; Mochalova L; Harder T; Tuzikov A; Bovin N; Wolff T; Matrosovich M; Schweiger B
J Virol; 2015 May; 89(10):5395-405. PubMed ID: 25741006
[TBL] [Abstract][Full Text] [Related]
52. Receptor binding specificity of recent human H3N2 influenza viruses.
Kumari K; Gulati S; Smith DF; Gulati U; Cummings RD; Air GM
Virol J; 2007 May; 4():42. PubMed ID: 17490484
[TBL] [Abstract][Full Text] [Related]
53. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.
Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA
J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028
[TBL] [Abstract][Full Text] [Related]
54. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation.
Saito T; Nakaya Y; Suzuki T; Ito R; Saito T; Saito H; Takao S; Sahara K; Odagiri T; Murata T; Usui T; Suzuki Y; Tashiro M
J Med Virol; 2004 Oct; 74(2):336-43. PubMed ID: 15332284
[TBL] [Abstract][Full Text] [Related]
55. Sequence analysis and receptor specificity of the hemagglutinin of a recent influenza H2N2 virus isolated from chicken in North America.
Glaser L; Zamarin D; Acland HM; Spackman E; Palese P; García-Sastre A; Tewari D
Glycoconj J; 2006 Feb; 23(1-2):93-9. PubMed ID: 16575526
[TBL] [Abstract][Full Text] [Related]
56. Single amino acid substitutions in the hemagglutinin can alter the host range and receptor binding properties of H1 strains of influenza A virus.
Aytay S; Schulze IT
J Virol; 1991 Jun; 65(6):3022-8. PubMed ID: 2033664
[TBL] [Abstract][Full Text] [Related]
57. Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin.
Igarashi M; Ito K; Kida H; Takada A
Virology; 2008 Jul; 376(2):323-9. PubMed ID: 18456302
[TBL] [Abstract][Full Text] [Related]
58. The hemagglutinin: a determinant of pathogenicity.
Böttcher-Friebertshäuser E; Garten W; Matrosovich M; Klenk HD
Curr Top Microbiol Immunol; 2014; 385():3-34. PubMed ID: 25031010
[TBL] [Abstract][Full Text] [Related]
59. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin.
Rogers GN; Paulson JC
Virology; 1983 Jun; 127(2):361-73. PubMed ID: 6868370
[TBL] [Abstract][Full Text] [Related]
60. [The effect of losing glycosylation sites near the receptor-binding region on the receptor phenotype of the human influenza virus H1N1].
Marinina VP; Gambarian AS; Bovin NV; Tuzikov AB; Shilov AA; Sinitsyn BV; Matrosovich MN
Mol Biol (Mosk); 2003; 37(3):550-5. PubMed ID: 12815964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
